Skip to content

Tandem Diabetes Care TNDM Equity Method Investments

Equity Method Investments at other companies

Mannkind logo
MannkindMNKD
$5.01M-8.6%
ICU Medical logo
ICU MedicalICUI
$130.92M+4,209%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$81.68M-13.3%
Cognizant logo
CognizantCTSH
$113M+20.2%
Insulet logo
InsuletPODD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-19.8%
Enterprise value$1.58B-8.5%
P/S-0.3×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's equity method investments?
Tandem Diabetes Care (TNDM) reported equity method investments of $56.49M in Q1 2026.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.